These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23615329)

  • 1. Hyperuricemia is an independent risk factor for mortality only if chronic kidney disease is present.
    Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    Am J Nephrol; 2013; 37(5):452-61. PubMed ID: 23615329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Guo W; Liu Y; Chen JY; Chen SQ; Li HL; Duan CY; Liu YH; Tan N
    Angiology; 2015 Sep; 66(8):721-6. PubMed ID: 25616679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
    Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of chronic total occlusion and chronic kidney disease in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Bataille Y; Plourde G; Machaalany J; Abdelaal E; Déry JP; Larose E; Déry U; Noël B; Barbeau G; Roy L; Costerousse O; Bertrand OF
    Am J Cardiol; 2013 Jul; 112(2):194-9. PubMed ID: 23601580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
    Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
    Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome.
    Dohi T; Kasai T; Miyauchi K; Takasu K; Kajimoto K; Kubota N; Amano A; Daida H
    J Cardiol; 2012 Dec; 60(6):438-42. PubMed ID: 23063662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
    Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
    Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel.
    Morel O; El Ghannudi S; Jesel L; Radulescu B; Meyer N; Wiesel ML; Caillard S; Campia U; Moulin B; Gachet C; Ohlmann P
    J Am Coll Cardiol; 2011 Jan; 57(4):399-408. PubMed ID: 21251579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of serum uric acid levels on mortality in acute coronary syndrome patients with chronic kidney disease after drug-eluting stent implantation.
    Yin Z; Fang Z; Yang M; Du X; Nie B; Gao K
    Cardiology; 2013; 125(4):204-12. PubMed ID: 23796962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender difference in the association of hyperuricemia with chronic kidney disease in southern China.
    Li Z; Liu Q; Mao H; Li Z; Dong X; Liu Y; Lin J; Chen W; Wang H; Johnson RJ; Yu X; Chen W
    Kidney Blood Press Res; 2012; 36(1):98-106. PubMed ID: 22948067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hyperuricemia on incident renal replacement therapy and all-cause mortality among patients with chronic kidney disease stages 3-5: a retrospective cohort study.
    Lee CL; Wang JS
    Sao Paulo Med J; 2019; 137(6):523-529. PubMed ID: 32159639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U-Shaped Association Between Serum Uric Acid Level and Risk of Mortality: A Cohort Study.
    Cho SK; Chang Y; Kim I; Ryu S
    Arthritis Rheumatol; 2018 Jul; 70(7):1122-1132. PubMed ID: 29694719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
    Farooq V; Serruys PW; Bourantas C; Vranckx P; Diletti R; Garcia Garcia HM; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; van Es GA; Steyerberg EW; Dawkins KD; Mohr FW; James S; Ståhle E
    Eur Heart J; 2012 Dec; 33(24):3105-13. PubMed ID: 23103663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
    Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.